Mirae Asset Global Investments Co., Ltd. Centessa Pharmaceuticals PLC Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,556 shares of CNTA stock, worth $46,493. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,556
Previous 1,730
47.75%
Holding current value
$46,493
Previous $15,000
166.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CNTA
# of Institutions
108Shares Held
118MCall Options Held
5.9KPut Options Held
53K-
Medicxi Ventures Management (Jersey) LTD20MShares$363 Million66.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$181 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$176 Million4.42% of portfolio
-
Perceptive Advisors LLC New York, NY6.28MShares$114 Million2.62% of portfolio
-
First Light Asset Management, LLC Edina, MN5.94MShares$108 Million8.27% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.72B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...